Dover (DOV)
(Delayed Data from NYSE)
$194.38 USD
-0.50 (-0.26%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $194.41 +0.03 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$194.38 USD
-0.50 (-0.26%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $194.41 +0.03 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Zacks News
Dover (DOV) Beats on Q1 Earnings, Suspends 2020 Guidance
by Zacks Equity Research
Dover's (DOV) bottom line improves year over year in Q1, as productivity initiatives and cost-control measures help mitigate the impact of the coronavirus pandemic on its top line.
Dover (DOV) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
While Dover's (DOV) Q1 results are likely to reflect gains from a solid order backlog and cost-reduction initiatives, the coronavirus outbreak and slowdown in the manufacturing industry are concerns.
Reasons to Hold Dover (DOV) Stock in Your Portfolio for Now
by Zacks Equity Research
Dover (DOV) is worth retaining in the portfolio at the moment, backed by encouraging outlook, robust backlog and cost-reduction initiatives.
Dover (DOV) to Buy Em-tec, Sees Growth in Biopharma Market
by Zacks Equity Research
The latest acquisition will help Dover (DOV) expand its offerings into biopharma and other hygienic applications.
Roper (ROP) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Roper (ROP) is likely to benefit from strength across its network software and medical products businesses, and acquisitions. However, soft Process Technologies segment is a concern.
Emerson (EMR) Launches Data Visualization Software Solution
by Zacks Equity Research
Emerson's (EMR) Micro Motion ProcessViz software solution supports its Micro Motion transmitters to provide plant operators with a snapshot of the flow process.
Federal Signal Announces Buyback Program, Launches Website
by Zacks Equity Research
Federal Signal (FSS) rewards shareholders with a $75-million stock buyback program. It unveils a website to make consumers aware of the use of its products to contain the coronavirus outbreak.
Parker-Hannifin Discusses Strategies and Long-Term Targets
by Zacks Equity Research
Parker-Hannifin's (PH) recent investor meeting shines a light on its organic initiatives, long-term financial targets and capital allocation plans.
Emerson Acquires Verdant, Strengthens Product Portfolio
by Zacks Equity Research
Emerson's (EMR) buyout of Verdant will enable it to boost portfolio of thermostat and sustainability solutions for the hotel and hospitality industries.
Chart Industries Authorizes $75M Share Repurchase Program
by Zacks Equity Research
Chart Industries (GTLS) remains committed toward rewarding its shareholders handsomely through share buyback programs.
Here's Why it is Worth Investing in Tennant (TNC) Stock Now
by Zacks Equity Research
Tennant (TNC) is likely to gain from product innovation, investments to expand capacity and synergistic benefits from acquired assets. Also, shareholder-friendly policies enhance its attractiveness.
Dover Divests Aftermarket Refrigeration Solutions Business
by Zacks Equity Research
Dover's (DOV) AMS group is a leading aftermarket refrigeration solutions and services provider business.
Berry Global (BERY) Increases Production to Fight Coronavirus
by Zacks Equity Research
Berry Global (BERY) highlights its participation in the fight against the deadly coronavirus, with increase in production of healthcare materials. Also, it commercializes new Spinlace production line.
Donaldson Extends Connected Filtration Service to Europe
by Zacks Equity Research
Donaldson's (DCI) iCue connected filtration service uses the Industrial IoT to monitor dust collectors and provides data and maintenance alerts on an instant basis.
Here's Why it is Worth Investing in Graco (GGG) Stock Now
by Zacks Equity Research
Graco (GGG) is likely to gain from product innovation, investments to expand capacity and prevailing top-line tailwinds. Also, shareholder-friendly policies enhance its attractiveness.
Middleby's Deutsche Beverage Buyout to Aid Beverage Business
by Zacks Equity Research
Middleby's (MIDD) Deutsche Beverage buyout is likely to expand product offerings in the beverage platform. It will complement the company's June 2019 acquisition of Ss Brewtech.
IDEX's (IEX) Flow Management Buyout to Boost Energy Business
by Zacks Equity Research
IDEX's (IEX) buyout of Flow Management Devices is likely to boost the energy business, especially from pipeline operators, refineries and chemical manufacturers.
Forget Caterpillar, Buy These 5 Industrial Stocks Instead
by Madhurima Das
While the near-term prospects for Caterpillar (CAT) look bleak at the moment, we suggest five industrial stocks that are poised better with positive growth projections and estimate revision activity.
Middleby (MIDD) Surpasses Q4 Earnings and Sales Estimates
by Zacks Equity Research
Middleby's (MIDD) Q4 results improve y/y on gains from acquired assets and improved operating results. Solid product offerings and acquisitions are likely to play key roles in the quarters ahead.
Is Enerpac Tool (EPAC) Stock a Promising Investment Option?
by Zacks Equity Research
Enerpac Tool's (EPAC) solid product portfolio, market expansion, strategic acquisitions and footprint optimization moves pose it well for growth.
Here's Why You Should Add Dover (DOV) to Your Portfolio Now
by Zacks Equity Research
An encouraging outlook, robust backlog, cost-reduction initiatives and solid growth projections make Dover (DOV) an attractive investment option.
Tetra Tech's Segue Buyout to Aid Government Services Unit
by Zacks Equity Research
Tetra Tech's (TTEK) Segue buyout to strengthen its business from commercial and government customers. Operations of Segue will be integrated with the company's Government Services Group.
Colfax to Gain From Solid Product Lines & Buyouts Amid Risks
by Zacks Equity Research
Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses and productivity actions, and gains from acquired assets. Cost of sales witnesses a rise.
ITT's Q4 Earnings & Revenues Surpass Estimates, Increase Y/Y
by Zacks Equity Research
ITT's Q4 earnings and revenues grow year over year on the back of solid segmental performances.
Barnes (B) Earnings Surpass Estimates in Q4, Sales Miss
by Zacks Equity Research
Barnes' (B) Q4 earnings benefit from improved operating results. Divestment of the Seeger business will likely affect the top line in 2020.